triptolide has been researched along with Parkinson Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gu, L; Huang, YY; Wang, XM; Xia, N; Yang, HM; Zhang, H; Zhang, JN; Zhang, Q; Zhang, YN | 1 |
Hao, J; Li, J | 1 |
Li, F; Lu, L; Wang, X | 1 |
Li, FQ; Liang, XB; Liu, XY; Wang, JJ; Wang, X; Wang, XM; Zhou, HF | 1 |
3 review(s) available for triptolide and Parkinson Disease
Article | Year |
---|---|
Treatment of Neurodegenerative Diseases with Bioactive Components of
Topics: Alzheimer Disease; Animals; Diterpenes; Epoxy Compounds; Humans; Medicine, Chinese Traditional; Molecular Conformation; Neurodegenerative Diseases; Neuroprotective Agents; Parkinson Disease; Pentacyclic Triterpenes; Phenanthrenes; Phytotherapy; Tripterygium; Triterpenes | 2019 |
Novel anti-inflammatory and neuroprotective agents for Parkinson's disease.
Topics: Animals; Anti-Inflammatory Agents; Brain; Cytoprotection; Diterpenes; Encephalitis; Epoxy Compounds; Glatiramer Acetate; Humans; Microglia; Minocycline; Neuroprotective Agents; Parkinson Disease; Peptides; Phenanthrenes | 2010 |
Therapeutic strategies for Parkinson's disease: the ancient meets the future--traditional Chinese herbal medicine, electroacupuncture, gene therapy and stem cells.
Topics: Animals; Diterpenes; Electroacupuncture; Epoxy Compounds; Genetic Therapy; Glutamate Decarboxylase; Humans; Medicine, Chinese Traditional; Parkinson Disease; Phenanthrenes; Stem Cell Transplantation | 2008 |
1 other study(ies) available for triptolide and Parkinson Disease
Article | Year |
---|---|
Triptolide up-regulates metabotropic glutamate receptor 5 to inhibit microglia activation in the lipopolysaccharide-induced model of Parkinson's disease.
Topics: Animals; Cell Line; Disease Models, Animal; Diterpenes; Dopaminergic Neurons; Epoxy Compounds; Inflammation; Interleukin-1beta; Lipopolysaccharides; Macrophage Activation; Male; Mice; Microglia; Nitric Oxide; Nitric Oxide Synthase Type II; Parkinson Disease; Phenanthrenes; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Signal Transduction; Transcriptional Activation; Tumor Necrosis Factor-alpha; Up-Regulation | 2018 |